Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 1552 to 1601 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSLATION INITIATION FACTOR EIF-2B BETA SUBUNIT (EIF-2B GDP-GTP EXCHANGE FACTOR) (S20I15) (S20III15). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.415409\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.71958\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24157585\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF2B2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH [INCLUDES: PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE (EC 2.1.2.3) (AICAR TRANSFORMYLASE); IMP CYCLOHYDROLASE (EC 3.5.4.10) (INOSINICASE) (IMP SYNTHETASE) (ATIC)]. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.100408\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.416\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.241365385\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATIC\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE (EC 6.3.5.3) (FGAM SYNTHASE) (FGAMS) (FORMYLGLYCINAMIDE RIBOTIDE AMIDOTRANSFERASE) (FGARAT) (FORMYLGLYCINAMIDE RIBOTIDE SYNTHETASE). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
PFAS\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MULTIFUNCTIONAL PROTEIN ADE2 [INCLUDES: PHOSPHORIBOSYLAMINOIMIDAZOLE- SUCCINOCARBOXAMIDE SYNTHASE (EC 6.3.2.6) (SAICAR SYNTHETASE); PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE (EC 4.1.1.21) (AIR CARBOXYLASE) (AIRC)]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.200816\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.832\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
PAICS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1556\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.184977\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.766628\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241286517\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1557\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0753661\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.312352\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241285793\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GC-RICH SEQUENCE DNA-BINDING FACTOR HOMOLOG. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.037683\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.156176\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.241285473\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
C21orf66\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TOLL-LIKE RECEPTOR 2 PRECURSOR (TOLL/INTERLEUKIN 1 RECEPTOR-LIKE PROTEIN 4). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
TLR2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"THIOREDOXIN INTERACTING PROTEIN; UPREGULATED BY 1,25-DIHYDROXYVITAMIN D-3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0419848\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.174068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241197693\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TXNIP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1561\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0442559\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.183485\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241196283\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARRDC4\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1562\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.0467541\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.193844\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241194466\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARRDC3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1563\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
U3 SMALL NUCLEOLAR RIBONUCLEOPROTEIN PROTEIN MPP10 (M PHASE PHOSPHOPROTEIN 10). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.63619\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.6381\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241154619\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MPHOSPH10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GCN5-LIKE PROTEIN 1 (RT14 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.223546\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.927081\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241128877\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BLOC1S1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROLIFERATING-CELL NUCLEOLAR ANTIGEN P120 (PROLIFERATION-ASSOCIATED NUCLEOLAR PROTEIN P120). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.714168\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.96197\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.241112503\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NOL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 1. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0394801\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.163824\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.240990941\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARL1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEFA-INTERACTING NUCLEAR PROTEIN NIP30. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1568\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOCHONDRIAL 28S RIBOSOMAL PROTEIN S22 (S22MT) (MRP-S22) (GK002). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.070166\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.291157\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.240990256\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
MRPS22\vspace{3pt}}\\\cline{1-4}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1569\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEASOME SUBUNIT BETA TYPE 2 (EC 3.4.25.1) (PROTEASOME COMPONENT C7-I) (MACROPAIN SUBUNIT C7-I) (MULTICATALYTIC ENDOPEPTIDASE COMPLEX SUBUNIT C7-I). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.966048\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.00866\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
PSMB2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIM HOMEOBOX TRANSCRIPTION FACTOR 1 BETA (LIM/HOMEOBOX PROTEIN LMX1B) (LIM-HOMEOBOX PROTEIN 1.2) (LMX-1.2). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0789602\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.327649\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.240990206\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
LMX1B\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIM HOMEOBOX TRANSCRIPTION FACTOR 1 ALPHA (LIM/HOMEOBOX PROTEIN LMX1A) (LIM-HOMEOBOX PROTEIN 1.1) (LMX-1.1). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
LMX1A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOCHONDRIAL PRECURSOR PROTEINS IMPORT RECEPTOR (TRANSLOCASE OF OUTER MEMBRANE TOM70). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.11844\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.491473\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240989841\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TOMM70A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BULLOUS PEMPHIGOID ANTIGEN 1 ISOFORMS 1/2/3/4/5/8 (230 KDA BULLOUS PEMPHIGOID ANTIGEN) (BPA) (HEMIDESMOSOMAL PLAQUE PROTEIN) (DYSTONIA MUSCULORUM PROTEIN) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0777867\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.322851\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240936841\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DST\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"MICROTUBULE-ACTIN CROSSLINKING FACTOR 1, ISOFORM 4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0946162\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.392702\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240936384\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MACF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ACTIN, CYTOPLASMIC 2 (GAMMA-ACTIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.228182\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.947072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240934163\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACTG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RIBOKINASE (EC 2.7.1.15). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.102962\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.427411\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240896935\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RBKS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERPIN B12. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0598165\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.248312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240892506\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SERPINB12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UPF0183 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0385664\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.160098\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240892453\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C16orf70\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OXYSTEROLS RECEPTOR LXR-ALPHA (LIVER X RECEPTOR ALPHA) (NUCLEAR ORPHAN RECEPTOR LXR-ALPHA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.110811\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.460002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240892431\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NR1H3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SQUAMOUS CELL CARCINOMA ANTIGEN 1 (SCCA-1) (PROTEIN T4-A). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0820308\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.340529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240892259\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SERPINB4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEGSIN (TP55) (SERPIN B7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.056548\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.234744\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240892206\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SERPINB7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OXYSTEROLS RECEPTOR LXR-BETA (LIVER X RECEPTOR BETA) (NUCLEAR ORPHAN RECEPTOR LXR-BETA) (UBIQUITOUSLY-EXPRESSED NUCLEAR RECEPTOR) (NUCLEAR RECEPTOR NER). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0824164\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.34213\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240892059\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NR1H2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSLATION INITIATION FACTOR EIF-2B ALPHA SUBUNIT (EIF-2B GDP-GTP EXCHANGE FACTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.692768\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.87585\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240891562\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF2B1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HURPIN (HACAT UV-REPRESSIBLE SERPIN) (PROTEASE INHIBITOR 13) (HEADPIN) (SERPIN B13). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0653411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.271247\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240891512\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANTITHROMBIN-III PRECURSOR (ATIII) (PRO0309). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0555356\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.230542\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240891464\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SERPINC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EUKARYOTIC TRANSLATION INITIATION FACTOR 5A (EIF-5A) (EIF-4D) (REV- BINDING FACTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.376553\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.56403\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.24075817\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF5AP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0612982\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.25461\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240753309\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CHAC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF-5A2 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.326192\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.35491\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240748094\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EIF5A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HIV-1 REV BINDING PROTEIN 2; REV INTERACTING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.501293\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.08327\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240627955\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KRR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EVOLUTIONARILY CONSERVED SIGNALING INTERMEDIATE IN TOLL PATHWAY; ECSIT. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.28028\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.16562\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240455723\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ECSIT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BYSTIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.784986\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.26689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240285409\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BYSL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LAMIN A/C (70 KDA LAMIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.175549\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.730667\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240258558\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LMNA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTAURIN BETA 5 (CNT-B5). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0606318\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.252363\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240256297\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CENTB5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTAURIN BETA 1 (CNT-B1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.058923\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.245251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240255901\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CENTB1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CENTAURIN BETA 2 (CNT-B2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0726324\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.302313\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240255629\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CENTB2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LAMIN B1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.210907\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.877854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240252935\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LMNB1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PUTATIVE EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT (EIF-3) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.275535\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.14705\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240211848\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KIAA0664\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE PROTEIN PHOSPHATASE 4 (EC 3.1.3.16) (PP4) (PROTEIN PHOSPHATASE X) (PP-X). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.161804\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.67395\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240083092\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP4C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMMUNOGLOBULIN-BINDING PROTEIN 1 (CD79A-BINDING PROTEIN 1) (B CELL SIGNAL TRANSDUCTION MOLECULE ALPHA 4) (ALPHA 4 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0337232\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.140465\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240082583\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
IGBP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSLIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.218752\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.911432\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240009128\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSLIN-ASSOCIATED PROTEIN X (TRANSLIN-ASSOCIATED FACTOR X). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0312503\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.130205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.240008448\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TSNAX\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/